Mapi Research Trust appointed as exclusive distributor and Mapi Language Services as exclusive translator of the "Quality of Life - Alzheimer's Disease" measure (QOL-AD)

LYON, France, May 23, 2017 /PRNewswire/ -- Mapi Research Trust, the leading curator and license distributor of Clinical Outcome Assessments (COAs) and Mapi Language Services, the most trusted provider of linguistic validation, have been selected by Dr Rebecca Logsdon, the author of the "Quality of Life – Alzheimer's Disease" measure (QOL-AD) to be the exclusive licensor, distributor and translator of the QOL-AD and all its derivatives for the scientific community.

The QOL-AD is a brief, 13-item measure, originally described in a research study published by Drs Logsdon, Gibbons, McCurry and Teri in 1999, and designed specifically to obtain a rating of the patient's Quality of Life from both the patient and the caregiver. It includes assessments of the individual's relationships with friends and family, concerns about finances, physical condition, mood, and an overall assessment of quality of life. "Collaborating with Mapi has led to the production of over 55 high-quality and harmonized translations of the QOL-AD and their large dissemination within the scientific community through an easy and controlled access," said Rebecca Logsdon.

"Our mission is to provide vital assistance to authors in the daily management of their questionnaires, relieving them from the administrative burden of the distribution, licensing and handling of requests from users," said Katrin Conway, Managing Director of the Mapi Research Trust. "The distribution of the QOL-AD by Mapi will facilitate the access to the original questionnaire and all its derivatives such as translations and electronic versions while respecting the integrity and copyright of Dr Logsdon's questionnaire," she added.

"We are honored to serve the QOL-AD and Dr Logsdon by ensuring consistency across translations and between paper and electronic versions of the questionnaire. This measure, largely used both in clinical research and practice, deserves the highest linguistic validation and electronic migration standards established by Mapi for years, for the benefit of the whole scientific community," commented Ana Bayles, Global Director – Mapi Language Services.

For any request about the QOL-AD or to view the QOL-AD's description, please consult https://eprovide.mapi-trust.org/

About Mapi Language Services:

Mapi Language Services is the worldwide leader in medical translation and Linguistic Validation of COAs for nearly 3 decades. Mapi has first-hand knowledge of local languages and cultures, regulations, and healthcare practices. We work in close collaboration with developers, assure conceptual equivalence and international harmonization of all language versions. Mapi Language Services' experience represents more than 40,000 translated versions of 2,500 Questionnaires in 170 languages.  Visit http://www.mapigroup.com for more information.

About Mapi Research Trust:

Mapi Research Trust is a Non-Profit arm of Mapi Group and works in collaboration with Academic Researchers, Life-Science Companies and Regulatory bodies. It is the largest curator of Clinical Outcomes Assessments (COA) and their translations, the largest single COA licensing provider and the most trusted name in distribution of COA instruments exclusively representing over 300 questionnaires.  Visit http://mapi-trust.org/ for more information.

About Dr Rebecca Logsdon: 

Dr Rebecca Logsdon is Research Professor Emeritus, Department of Psychosocial and Community Health, University of Washington School of Nursing. As clinical psychologist specializing in gerontology, Dr. Logsdon's 30-year research career has focused on psychosocial interventions to improve mental and physical health and quality of life for individuals with memory loss and their families. She is co-editor of a book on assessing quality of life in Alzheimer's disease, has over 100 scientific research publications, is a fellow of the Gerontological Society of America, and serves as a regular reviewer for NIH grant proposals.
Press contact: [email protected]

SOURCE Mapi Research Trust

Related Links

http://mapi-trust.org